Matches in Nanopublications for { ?s ?p "[The expression of transforming growth factor alpha (TGFalpha), amphiregulin (AR) and cripto-1 (CR-1) was assessed by immunohistochemistry in 83 specimens (59 primary ovarian tumors and 24 extra-ovarian carcinomas) that were obtained from 68 ovarian carcinoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 11 of
11
with 100 items per page.
- NP155991.RAaKBCJH4TVp87d6nx2APuCrcpTP5v9llYZHeXiNNAUzc130_assertion description "[The expression of transforming growth factor alpha (TGFalpha), amphiregulin (AR) and cripto-1 (CR-1) was assessed by immunohistochemistry in 83 specimens (59 primary ovarian tumors and 24 extra-ovarian carcinomas) that were obtained from 68 ovarian carcinoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP155991.RAaKBCJH4TVp87d6nx2APuCrcpTP5v9llYZHeXiNNAUzc130_provenance.
- assertion description "[The expression of transforming growth factor alpha (TGFalpha), amphiregulin (AR) and cripto-1 (CR-1) was assessed by immunohistochemistry in 83 specimens (59 primary ovarian tumors and 24 extra-ovarian carcinomas) that were obtained from 68 ovarian carcinoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP634063.RAikIy9BPfS4oQXAcWB683PqyFJvBeilTBMediZPi4AVc130_assertion description "[The expression of transforming growth factor alpha (TGFalpha), amphiregulin (AR) and cripto-1 (CR-1) was assessed by immunohistochemistry in 83 specimens (59 primary ovarian tumors and 24 extra-ovarian carcinomas) that were obtained from 68 ovarian carcinoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP634063.RAikIy9BPfS4oQXAcWB683PqyFJvBeilTBMediZPi4AVc130_provenance.
- NP439417.RAdfYn3ZqrGjHBQeQvf121eoQ44fVXdmwlQC0yWEn1FL8130_assertion description "[The expression of transforming growth factor alpha (TGFalpha), amphiregulin (AR) and cripto-1 (CR-1) was assessed by immunohistochemistry in 83 specimens (59 primary ovarian tumors and 24 extra-ovarian carcinomas) that were obtained from 68 ovarian carcinoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP439417.RAdfYn3ZqrGjHBQeQvf121eoQ44fVXdmwlQC0yWEn1FL8130_provenance.
- NP718954.RAVnt3FGJnjmH4jL7ZQ-u8ENFK6LnDyrt_xIu9Hwb56Po130_assertion description "[The expression of transforming growth factor alpha (TGFalpha), amphiregulin (AR) and cripto-1 (CR-1) was assessed by immunohistochemistry in 83 specimens (59 primary ovarian tumors and 24 extra-ovarian carcinomas) that were obtained from 68 ovarian carcinoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718954.RAVnt3FGJnjmH4jL7ZQ-u8ENFK6LnDyrt_xIu9Hwb56Po130_provenance.
- assertion description "[The expression of transforming growth factor alpha (TGFalpha), amphiregulin (AR) and cripto-1 (CR-1) was assessed by immunohistochemistry in 83 specimens (59 primary ovarian tumors and 24 extra-ovarian carcinomas) that were obtained from 68 ovarian carcinoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The expression of transforming growth factor alpha (TGFalpha), amphiregulin (AR) and cripto-1 (CR-1) was assessed by immunohistochemistry in 83 specimens (59 primary ovarian tumors and 24 extra-ovarian carcinomas) that were obtained from 68 ovarian carcinoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP251709.RAlR8zK9206umDn9k2nCxpqSLOSPNmyfJQAB59KxkeckI130_assertion description "[The expression of transforming growth factor alpha (TGFalpha), amphiregulin (AR) and cripto-1 (CR-1) was assessed by immunohistochemistry in 83 specimens (59 primary ovarian tumors and 24 extra-ovarian carcinomas) that were obtained from 68 ovarian carcinoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP251709.RAlR8zK9206umDn9k2nCxpqSLOSPNmyfJQAB59KxkeckI130_provenance.
- NP370283.RAQKsNhXDfOuWABl0j0Fzcbk4JDnwvMTsPyBNZQVFFdMw130_assertion description "[The expression of transforming growth factor alpha (TGFalpha), amphiregulin (AR) and cripto-1 (CR-1) was assessed by immunohistochemistry in 83 specimens (59 primary ovarian tumors and 24 extra-ovarian carcinomas) that were obtained from 68 ovarian carcinoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP370283.RAQKsNhXDfOuWABl0j0Fzcbk4JDnwvMTsPyBNZQVFFdMw130_provenance.
- NP726756.RAtA9n4fEMW8uJ0LiNCIVn9XR8Tth8V6cODokqxbeG3W0130_assertion description "[The expression of transforming growth factor alpha (TGFalpha), amphiregulin (AR) and cripto-1 (CR-1) was assessed by immunohistochemistry in 83 specimens (59 primary ovarian tumors and 24 extra-ovarian carcinomas) that were obtained from 68 ovarian carcinoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP726756.RAtA9n4fEMW8uJ0LiNCIVn9XR8Tth8V6cODokqxbeG3W0130_provenance.
- NP370282.RAzsD6A-2Cxm4ocAz3XqTZLjFD1W6aLINMI_iyAJWd140130_assertion description "[The expression of transforming growth factor alpha (TGFalpha), amphiregulin (AR) and cripto-1 (CR-1) was assessed by immunohistochemistry in 83 specimens (59 primary ovarian tumors and 24 extra-ovarian carcinomas) that were obtained from 68 ovarian carcinoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP370282.RAzsD6A-2Cxm4ocAz3XqTZLjFD1W6aLINMI_iyAJWd140130_provenance.